Fig. 5From: Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacyInhibition of cell growth by curcumin (CUR) and paclitaxel (PTX) individual as a drug free form and drug niosomal form in MCF-7 and MCF-10A cell. a Free CUR; b Free PTX; c Nio CUR; d Nio PTX for MCF-7 (filled square) and MCF-10A (filled triangle) cellsBack to article page